Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Stocks

Major Shareholder Trims Stake in Empire State Realty Trust

Robert Sasse by Robert Sasse
August 24, 2025
in Stocks
0
Empire State Realty Stock
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

Vanguard Group has reduced its investment position in Empire State Realty Trust by 0.6%, bringing its total holdings to approximately 19.7 million shares. This stake represents about 11.76% of the company’s outstanding shares. Adjustments of this nature by significant institutional investors frequently signal a cautious reassessment of a company’s future outlook.

From a technical analysis perspective, the stock is displaying weakness. It is currently trading below its key moving averages, with the 50-day average at $7.84 and the 200-day average at $7.94—a configuration often interpreted as a bearish indicator. Over the past year, the share price has fluctuated between a low of $6.56 and a high of $11.62.

Mixed Operational Performance and Revised Guidance

The company’s recent operational metrics present a mixed picture:
* Q2 2025 Core FFO: $0.22 per share, which met analyst expectations.
* Same-Property NOI: Declined by 3% after adjustments.
* Empire State Building Observatory NOI: Totaled $24 million, reflecting a 4.3% decrease from the previous year.

In response to these results, management has revised its full-year 2025 projections downward. The company now anticipates Observatory NOI to land between $90 million and $94 million. Furthermore, the forecast for Core FFO per share has been set in a range of $0.83 to $0.86.

Should investors sell immediately? Or is it worth buying Empire State Realty?

Wall Street’s Cautious Stance

Analyst sentiment toward Empire State Realty Trust remains skeptical. While the average price target sits at $10.43, one firm recently downgraded the stock from a “Hold” to a “Sell” recommendation. A Citi analyst maintained a “Hold” rating in August, accompanied by a price target of $8.00. The current consensus price target is $8.56.

Strong Balance Sheet and Dividend

Despite these operational headwinds and cautious sentiment, the company maintains a robust financial position:
* Current Ratio: 4.03
* Quick Ratio: 4.03
* Debt-to-Equity: 1.15

Empire State Realty Trust continues its shareholder returns through a quarterly dividend of $0.035 per share. This distribution provides an annualized yield of 1.9% and is scheduled for payment on September 30.

Ad

Empire State Realty Stock: Buy or Sell?! New Empire State Realty Analysis from February 7 delivers the answer:

The latest Empire State Realty figures speak for themselves: Urgent action needed for Empire State Realty investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Empire State Realty: Buy or sell? Read more here...

Tags: Empire State Realty
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Eli Lilly Stock
Stocks

Eli Lilly’s Strategic Diversification Amid Weight-Loss Drug Competition

November 18, 2025
Micron Stock
Stocks

Micron Shares Approach Peak: What Comes After the AI Rally?

November 18, 2025
Varonis Stock
Stocks

Varonis Shares Plunge Amidst Mixed Signals

November 18, 2025
Next Post
PJT Stock

Navigating Crisis and Capital: PJT Partners' Dual Role in High-Stakes Finance

Idexx Laboratories Stock

Idexx Laboratories: A Market Leader at a Critical Juncture

Adobe Stock

Adobe Stock Surges on Unprecedented Trading Activity

Recommended

C3.ai Stock

Is C3.ai Stock Poised for a Rebound?

2 months ago
MMM stock news

Clarification on Hyperlink and Promotional Fees

2 years ago

XOMA Corporation Expands Portfolio with Acquisition of DSUVIA

2 years ago
Microsoft Stock

A Bold Bet: Peter Thiel’s Hedge Fund Doubles Down on Microsoft

1 month ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

ServiceNow Shares Face Market Skepticism Despite Record Performance

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

A New Chapter for First Busey as CrossFirst Merger Finalizes

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Trending

Avanos Medical Stock
Analysis

Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth

by SiterGedge
February 7, 2026
0

Avanos Medical is navigating a critical strategic transformation. The medical device firm is streamlining its operations to...

Guaranty Bancshares Stock

Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion

February 7, 2026
Yirendai Stock

Yirendai Charts a New Course with Tech-Driven Strategy

February 7, 2026
ServiceNow Stock

ServiceNow Shares Face Market Skepticism Despite Record Performance

February 7, 2026
Orthofix Medical Stock

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth
  • Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion
  • Yirendai Charts a New Course with Tech-Driven Strategy

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com